Insider Trades
News
globenewswire.comAnnovis Bio Regains NYSE Listing Complianceglobenewswire.comMay 26
globenewswire.comAnnovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrantsglobenewswire.comMay 20
globenewswire.comAnnovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrantsglobenewswire.comMay 19
globenewswire.comAnnovis Provides Corporate Updates and Reports First Quarter 2026 Financial Resultsglobenewswire.comMay 15
globenewswire.comAnnovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026globenewswire.comMay 7